Thermo Fisher Raises $1.5B Debt To Fund Patheon Acquisition

Law360, New York (August 11, 2017, 2:37 PM EDT) -- Thermo Fisher Scientific Inc. said Friday it priced a two-part, $1.5 billion debt offering to help fund its acquisition of Dutch pharmaceutical contract development and manufacturing company Patheon NV, three days after it raised $1.5 billion in stock to support the purchase.

The scientific and medical equipment company, advised by WilmerHale, told regulators it priced two tranches of investment-grade bonds totaling $750 million each, one maturing in 10 years and the other in 30 years. The bonds pay annual interest rates of 3.2 and 4.1 percent...
To view the full article, register now.